On Drug Pricing, States Step In Where Washington Fails


Large pharmaceutical companies may be in trouble as state legislatures nationwide are passing laws that force big pharma to be more transparent about their prices, and forcing the utilization of generic alternatives under Medicaid coverage. Additionally, some states are pushing to allow patients to order the prescriptions they need from companies in Canada who are willing to sell the same drugs at a much lower cost to the consumer. These policies encourage free-market competition that may lower the cost of life-saving medications in the near future.

Related Stories